• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

双相情感障碍患者的呼吸系统疾病:一项系统评价与荟萃分析。

Respiratory disease in people with bipolar disorder: a systematic review and meta-analysis.

作者信息

Laguna-Muñoz David, Jiménez-Peinado Ana, Jaén-Moreno María José, Camacho-Rodríguez Cristina, Del Pozo Gloria Isabel, Vieta Eduard, Caballero-Villarraso Javier, Khan Muhammad Ijlal, Rico-Villademoros Fernando, Sarramea Fernando

机构信息

Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Córdoba, Spain.

Reina Sofia University Hospital, Córdoba, Spain.

出版信息

Mol Psychiatry. 2025 Feb;30(2):777-785. doi: 10.1038/s41380-024-02793-1. Epub 2024 Nov 14.

DOI:10.1038/s41380-024-02793-1
PMID:39543369
Abstract

People with bipolar disorder (BD) have an increased risk of premature mortality and the respiratory mortality rate is higher than those of the general population. To date, however, the evidence on respiratory disease in this population has not been meta-analyzed. We systematically review and meta-analyze the frequency of respiratory diseases in patients with BD and to compare prevalence and odds ratio (OR) with the general population. The systematic literature search was conducted in Pubmed, PsycINFO, Scielo and Scopus, with snowball search of reference and citation lists. Inclusion criteria were studies reporting diagnoses of respiratory diseases (asthma, chronic obstructive pulmonary disease (COPD), pneumonia, lung cancer and tuberculosis) in people with BD according to operationalized criteria and where possible, control group. Of the 2158 articles screened, 20 including 962,352 people with BD and 37,340,405 control group, met the inclusion criteria. In people with BD, the prevalence of COPD was 9.14% (95%CI: 6.61-12.5%), asthma 6.4% (95%CI: 4.56-8.91%), pneumonia 2.78% (95%CI: 2.51-3.08%) and lung cancer 0.44% (95%CI:0.23-0.84%). Compared to the general population, people with BD had significantly higher rates of COPD (OR: 1.73; 95% CI: 1.40-2.14), showing an increased rate in younger and female patients; asthma (OR: 1.91, 95% CI: 1.25-2.94), with a greater rate in younger patients; and pneumonia (OR: 2.82, 95% CI: 1.33-5.99). In the first meta-analysis on the topic, BD was associated with an increased risk of respiratory illness versus the general population. In COPD and asthma, young people and women are at particular risk. Prevention programs are urgently needed.

摘要

双相情感障碍(BD)患者过早死亡的风险增加,其呼吸系统死亡率高于普通人群。然而,迄今为止,关于该人群呼吸系统疾病的证据尚未进行荟萃分析。我们系统地回顾并荟萃分析了BD患者呼吸系统疾病的发生频率,并将其患病率和比值比(OR)与普通人群进行比较。在PubMed、PsycINFO、Scielo和Scopus数据库中进行了系统的文献检索,并通过对参考文献和引用列表进行滚雪球式检索。纳入标准为根据可操作标准报告BD患者呼吸系统疾病(哮喘、慢性阻塞性肺疾病(COPD)、肺炎、肺癌和肺结核)诊断的研究,如有可能,还需有对照组。在筛选的2158篇文章中,有20篇符合纳入标准,共纳入962352例BD患者和37340405例对照组。在BD患者中,COPD的患病率为9.14%(95%CI:6.61 - 12.5%),哮喘为6.4%(95%CI:4.56 - 8.91%),肺炎为2.78%(95%CI:2.51 - 3.08%),肺癌为0.44%(95%CI:0.23 - 0.84%)。与普通人群相比,BD患者的COPD发生率显著更高(OR:1.73;95%CI:1.40 - 2.14),在年轻患者和女性患者中发生率更高;哮喘(OR:1.91,95%CI:1.25 - 2.94),在年轻患者中发生率更高;肺炎(OR:2.82,95%CI:1.33 - 5.99)。在该主题的首次荟萃分析中,BD与普通人群相比呼吸系统疾病风险增加相关。在COPD和哮喘方面,年轻人和女性尤其危险。迫切需要预防项目。

相似文献

1
Respiratory disease in people with bipolar disorder: a systematic review and meta-analysis.双相情感障碍患者的呼吸系统疾病:一项系统评价与荟萃分析。
Mol Psychiatry. 2025 Feb;30(2):777-785. doi: 10.1038/s41380-024-02793-1. Epub 2024 Nov 14.
2
Combined corticosteroid and long-acting beta(2)-agonist in one inhaler versus long-acting beta(2)-agonists for chronic obstructive pulmonary disease.联合使用皮质类固醇和长效β2受体激动剂的单一吸入器与长效β2受体激动剂治疗慢性阻塞性肺疾病的比较
Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD006829. doi: 10.1002/14651858.CD006829.pub2.
3
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.
4
Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis.慢性阻塞性肺疾病的长效吸入疗法(β受体激动剂、抗胆碱能药物和类固醇):一项网状荟萃分析。
Cochrane Database Syst Rev. 2014 Mar 26;2014(3):CD010844. doi: 10.1002/14651858.CD010844.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Increased rates of respiratory disease in schizophrenia: A systematic review and meta-analysis including 619,214 individuals with schizophrenia and 52,159,551 controls.精神分裂症患者呼吸系统疾病发病率增高:一项包含 619214 例精神分裂症患者和 52159551 例对照者的系统评价和荟萃分析。
Schizophr Res. 2021 Nov;237:131-140. doi: 10.1016/j.schres.2021.08.022. Epub 2021 Sep 11.
7
Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease.长效毒蕈碱拮抗剂(LAMA)联合长效β-激动剂(LABA)与 LABA 联合吸入皮质类固醇(ICS)治疗稳定期慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD012066. doi: 10.1002/14651858.CD012066.pub3.
8
Inhaled corticosteroids versus placebo  for stable chronic obstructive pulmonary disease.吸入皮质类固醇与安慰剂治疗稳定期慢性阻塞性肺疾病。
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD002991. doi: 10.1002/14651858.CD002991.pub4.
9
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
10
Umeclidinium bromide versus placebo for people with chronic obstructive pulmonary disease (COPD).溴化乌美溴铵对比安慰剂用于慢性阻塞性肺疾病(COPD)患者。
Cochrane Database Syst Rev. 2017 Jun 20;6(6):CD011897. doi: 10.1002/14651858.CD011897.pub2.

引用本文的文献

1
Respiratory disease in people with major depressive disorder: A systematic review and Meta-analysis.重度抑郁症患者的呼吸系统疾病:一项系统评价与Meta分析
Eur Psychiatry. 2025 Feb 5;68(1):e34. doi: 10.1192/j.eurpsy.2025.13.

本文引用的文献

1
Real-world data on severe lung cancer: a multicenter retrospective study.重度肺癌的真实世界数据:一项多中心回顾性研究。
Transl Lung Cancer Res. 2023 Mar 31;12(3):460-470. doi: 10.21037/tlcr-23-4. Epub 2023 Mar 27.
2
The elephant in the room: Medication as confounder.房间里的大象:药物作为混杂因素。
Eur Neuropsychopharmacol. 2023 Jun;71:6-8. doi: 10.1016/j.euroneuro.2023.03.001. Epub 2023 Mar 15.
3
Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction.
精神障碍对躯体疾病临床结局的影响:一项评估人群归因分数和广义影响分数的综合综述
World Psychiatry. 2023 Feb;22(1):86-104. doi: 10.1002/wps.21068.
4
Clinical characteristics, outcomes, and factors associated with mortality in Nocardia pneumonia: 18 years' real-world data from a tertiary care hospital in Karachi, Pakistan.诺卡菌肺炎的临床特征、结局及与死亡率相关的因素:来自巴基斯坦卡拉奇一家三级医疗医院的18年真实世界数据。
Respir Investig. 2023 Mar;61(2):254-260. doi: 10.1016/j.resinv.2022.11.004. Epub 2022 Dec 18.
5
Lung Cancer Screening.肺癌筛查。
Semin Respir Crit Care Med. 2022 Dec;43(6):839-850. doi: 10.1055/s-0042-1757885. Epub 2022 Nov 28.
6
Prenatal and perinatal risk factors for bipolar disorder: A systematic review and meta-analysis.双相情感障碍的产前和围产期危险因素:一项系统评价和荟萃分析。
Neurosci Biobehav Rev. 2023 Jan;144:104960. doi: 10.1016/j.neubiorev.2022.104960. Epub 2022 Nov 12.
7
Excess resource use and costs of physical comorbidities in individuals with mental health disorders: A systematic literature review and meta-analysis.精神健康障碍患者的身体合并症导致的资源过度使用和成本:一项系统文献综述和荟萃分析。
Eur Neuropsychopharmacol. 2023 Jan;66:14-27. doi: 10.1016/j.euroneuro.2022.10.001. Epub 2022 Nov 4.
8
Major adverse cardiovascular events following acute coronary syndrome in patients with bipolar disorder.双相障碍患者急性冠脉综合征后主要不良心血管事件。
Int J Cardiol. 2022 Sep 15;363:1-5. doi: 10.1016/j.ijcard.2022.06.036. Epub 2022 Jun 16.
9
Life expectancy and years of potential life lost in bipolar disorder: systematic review and meta-analysis.双相障碍患者的预期寿命和潜在寿命损失年数:系统评价和荟萃分析。
Br J Psychiatry. 2022 Sep;221(3):567-576. doi: 10.1192/bjp.2022.19.
10
Mapping multimorbidity in individuals with schizophrenia and bipolar disorders: evidence from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLAM BRC) case register.绘制精神分裂症和双相情感障碍个体的共病图谱:来自南伦敦和莫兹利国民保健信托基金会生物医学研究中心(SLAM BRC)病例登记处的证据。
BMJ Open. 2022 Jan 24;12(1):e054414. doi: 10.1136/bmjopen-2021-054414.